MGTX (MeiraGTx Holdings) Projected Sales Volume

Symbol and logo of brand MeiraGTx Corp (MGTX)

Sales dynamics expectations for MeiraGTx Holdings plc (MGTX), which brings together leading virologists to create gene vectors, show a value of 0.40, representing the current metric level. MeiraGTx Holdings plc (MGTX) is implementing advanced DNA correction methods to combat rare pathologies. Growth potential is supported by a lack of saturation in the ophthalmology drug niche and strategic partnerships with industry behemoths.

Company Expected Sales Volume: MeiraGTx Holdings plc (MGTX) for 07/04/2022 - 11/18/2026

MeiraGTx PLC (MGTX) - metric breakdowns and financial figures

- current price and projected stock value:
Basic company analysis:MGTX MeiraGTx PLC
Brand item of MeiraGTx Holdings

The long-term reliability of MeiraGTx Holdings plc (MGTX) is determined by the stability of future cash flows, which are assessed via the estimated revenue growth rate based on current operational activity. Analyzing the company's sales forecast model on GURU.Markets, an investor can see business expansion dynamics supported by the diversification of gene platforms and in-house manufacturing, which minimizes external risks and confirms the company's sustainable growth.

Who MeiraGTx Holdings plc competes with

Company Future Sales Volume TEM (Tempus AI)|Company Future Sales Qiagen Group|Company Projected Revenue Ionis Pharma IONS|RGEN - Company Future Sales Volume|RNA - Company Projected Revenue|Company Future Revenue CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Company Projected Revenue|Company Expected Revenue RARE (Ultragenyx)|Company Future Sales Volume BEAM|Projected Sales Volume Sarepta Corp|Company Projected Revenue Twist Bioscience, Inc. (TWST)|Company Future Sales Volume 10x Genomics TXG|Company Projected Revenue Intellia Therapeutics NTLA|Company Projected Revenue Volume STOK (Stoke Therapeutics, Inc.)|BLFS - Company Projected Revenue|Company Expected Sales Volume Wave Pharma|mazetx.com (MAZE) - Company Projected Revenue|SION - Company Future Sales|PRME (Prime Medicine Inc) - Projected Sales Volume|Taysha Gene Therapies, Inc. - Company Expected Revenue|Projected Sales Volume QURE|REGENXBIO Corp - Company Revenue Forecast|Company Projected Revenue Solid Biosciences SLDB|OCGN - Company Future Sales Volume|pacb.com - Projected Sales Volume|Benitec (BNTC) - Company Future Sales Volume|DSGN: Projected Sales Volume|RCKT - Company Future Sales|FDMT: Company Future Sales|Company Revenue Forecast LXEO (lexeotx.com)|Company Projected Revenue Korro Bio Inc. (KRRO)|Company Projected Revenue Volume EDIT|Projected Sales Volume SLN (Silence Therapeutics PLC)|Company Future Revenue PRQR|CDXS - Company Projected Revenue|SGMO (Sangamo Therapeutics) - Company Revenue Forecast|NAUT: Projected Sales Volume|Company Revenue Forecast MGX|DTIL (precisionbiosciences.com) - Projected Sales Volume|Company Revenue Forecast GBIO (Generation Bio Co.)|Company Projected Revenue Boundless Bio (BOLD)|Exicure - Company Revenue Forecast|Projected Sales Volume IMNN (imunon.com)|Company Future Sales Phio Pharmaceuticals (PHIO)|MBIO: Company Future Sales Volume|Company Future Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Projected Revenue|APDN - Company Future Sales|Company Future Sales Volume BLUE|Projected Sales Volume immunoprecise.com|Projected Sales Volume OMGA|Company Future Sales Singular Genomics Corp|Regulus Therapeutics - Company Future Sales Volume|SYRS (Syros Pharmaceuticals) - Company Expected Revenue|Telesis Bio Inc. - Projected Sales Volume|Company Future Revenue TCON (TRACON Pharmaceuticals Inc.)|UBX: Projected Sales Volume